Cynosure Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Buy |
918
+215
| +31% | +$95.7K | 0.05% | 271 |
|
|
2025
Q1 | $341K | Sell |
703
-60
| -8% | -$29.1K | 0.05% | 257 |
|
|
2024
Q4 | $307K | Sell |
763
-130
| -15% | -$52.4K | 0.05% | 211 |
|
|
2024
Q3 | $415K | Sell |
893
-643
| -42% | -$299K | 0.06% | 195 |
|
|
2024
Q2 | $720K | Buy |
1,536
+23
| +2% | +$10.8K | 0.12% | 125 |
|
|
2024
Q1 | $632K | Buy |
+1,513
| New | +$632K | 0.11% | 118 |
|